A vaccine for the most commonly reported sexually transmitted infection in the U.S.—the bacterial disease chlamydia—is now a substantial step closer to reality. On Monday, researchers reported that two of their vaccine candidates were found to be safe in a phase 1 clinical trial of 35 women. Though the trial wasn’t meant to prove their effectiveness, the vaccines also seemed to provoke an immune response to the bacteria in all volunteers.
[Source: gizmodo.com] [ Comments ] [See why this is trending]